Morgan Stanley’s Pfizer PFE Stock Holding History

Morgan Stanley’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.6B	Buy	92,685,370 +3,571,766	+4%	+$95.1M	0.16%	104
2025 Q4	$2.22B	Buy	89,113,604 +14,342,946	+19%	+$362M	0.13%	126
2025 Q3	$1.91B	Buy	74,770,658 +4,635,350	+7%	+$114M	0.12%	156
2025 Q2	$1.7B	Sell	70,135,308 -10,307,009	-13%	-$240M	0.11%	163
2025 Q1	$2.04B	Buy	80,442,317 +6,544,527	+9%	+$171M	0.15%	125
2024 Q4	$1.96B	Sell	73,897,790 -4,073,426	-5%	-$110M	0.14%	129
2024 Q3	$2.26B	Buy	77,971,216 +498,970	+0.6%	+$14.6M	0.16%	111
2024 Q2	$2.17B	Sell	77,472,246 -7,320,593	-9%	-$202M	0.17%	111
2024 Q1	$2.35B	Sell	84,792,839 -79,420,233	-48%	-$2.2B	0.19%	96
2023 Q4	$4.73B	Buy	164,213,072 +79,285,270	+93%	+$2.4B	0.21%	90
2023 Q3	$2.82B	Buy	84,927,802 +348,628	+0.4%	+$12.3M	0.29%	59
2023 Q2	$3.1B	Buy	84,579,174 +3,929,745	+5%	+$153M	0.31%	55
2023 Q1	$3.29B	Buy	80,649,429 +1,150,068	+1%	+$49.7M	0.35%	51
2022 Q4	$4.07B	Buy	79,499,361 +7,419,929	+10%	+$356M	0.46%	35
2022 Q3	$3.15B	Sell	72,079,432 -469,003	-0.6%	-$22.8M	0.43%	40
2022 Q2	$3.8B	Buy	72,548,435 +25,173,688	+53%	+$1.28B	0.49%	32
2022 Q1	$2.45B	Buy	47,374,747 +320,901	+0.7%	+$16.7M	0.33%	62
2021 Q4	$2.78B	Buy	47,053,846 +399,821	+0.9%	+$19.8M	0.34%	59
2021 Q3	$2.01B	Sell	46,654,025 -1,240,055	-3%	-$54.9M	0.27%	86
2021 Q2	$1.88B	Buy	47,894,080 +1,582,052	+3%	+$61.5M	0.25%	94
2021 Q1	$1.68B	Sell	46,312,028 -7,298,083	-14%	-$259M	0.25%	95
2020 Q4	$1.97B	Buy	53,610,111 +5,052,472	+10%	+$185M	0.3%	71
2020 Q3	$1.69B	Buy	48,557,639 +2,927,671	+6%	+$103M	0.33%	71
2020 Q2	$1.42B	Sell	45,629,968 -2,225,940	-5%	-$75.6M	0.31%	78
2020 Q1	$1.48B	Sell	47,855,908 -2,049,375	-4%	-$69.8M	0.4%	55
2019 Q4	$1.86B	Buy	49,905,283 +2,627,263	+6%	+$93.6M	0.43%	37
2019 Q3	$1.61B	Sell	47,278,020 -1,771,743	-4%	-$64.4M	0.43%	36
2019 Q2	$2.02B	Buy	49,049,763 +1,129,779	+2%	+$44.9M	0.54%	23
2019 Q1	$1.93B	Sell	47,919,984 -4,712,104	-9%	-$189M	0.55%	20
2018 Q4	$2.18B	Sell	52,632,088 -5,858,426	-10%	-$243M	0.65%	15
2018 Q3	$2.45B	Buy	58,490,514 +1,187,449	+2%	+$45.7M	0.61%	17
2018 Q2	$1.97B	Buy	57,303,065 +1,418,187	+3%	+$48.5M	0.53%	24
2018 Q1	$1.88B	Buy	55,884,878 +3,269,970	+6%	+$112M	0.52%	23
2017 Q4	$1.81B	Buy	52,614,908 +3,112,480	+6%	+$106M	0.49%	25
2017 Q3	$1.68B	Sell	49,502,428 -168,887	-0.3%	-$5.43M	0.5%	25
2017 Q2	$1.58B	Sell	49,671,315 -2,688,400	-5%	-$84.8M	0.48%	28
2017 Q1	$1.7B	Buy	52,359,715 +4,260,909	+9%	+$134M	0.52%	22
2016 Q4	$1.48B	Buy	48,098,806 +6,600,985	+16%	+$202M	0.49%	28
2016 Q3	$1.33B	Buy	41,497,821 +3,024,406	+8%	+$101M	0.46%	26
2016 Q2	$1.29B	Buy	38,473,415 +832,620	+2%	+$26.6M	0.46%	26
2016 Q1	$1.06B	Sell	37,640,795 -1,792,936	-5%	-$51.2M	0.41%	35
2015 Q4	$1.21B	Buy	39,433,731 +1,770,625	+5%	+$55.7M	0.44%	25
2015 Q3	$1.12B	Buy	37,663,106 +1,775,242	+5%	+$56.9M	0.41%	27
2015 Q2	$1.14B	Sell	35,887,864 -1,154,640	-3%	-$37.6M	0.4%	35
2015 Q1	$1.22B	Buy	37,042,504 +462,327	+1%	+$14.7M	0.45%	24
2014 Q4	$1.08B	Buy	36,580,177 +318,563	+0.9%	+$9.13M	0.4%	31
2014 Q3	$1.02B	Sell	36,261,614 -10,224	-0%	-$287K	0.39%	29
2014 Q2	$1.02B	Buy	36,271,838 +3,477,099	+11%	+$99.1M	0.4%	27
2014 Q1	$999M	Buy	32,794,739 +270,639	+0.8%	+$8.07M	0.42%	24
2013 Q4	$945M	Buy	32,524,100 +281,221	+0.9%	+$8.18M	0.4%	33
2013 Q3	$879M	Sell	32,242,879 -9,402,125	-23%	-$256M	0.42%	29
2013 Q2	$1.11B	Buy	+41,645,004	New	+$1.15B	0.56%	16

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley's PFE Position: Q1 2026 in Review

Morgan Stanley increased its Pfizer (PFE) stake by 4% in Q1 2026, buying an estimated $95.1M and bringing the position to 92,685,370 shares worth $2.6B. The position accounts for 0.16% of the portfolio, ranked #104.

Morgan Stanley first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.73B in Q4 2023. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Morgan Stanley held 92,685,370 shares of Pfizer worth $2.6B as of Q1 2026.
Morgan Stanley bought 3,571,766 Pfizer shares in Q1 2026, an estimated $95.1M.
Pfizer made up 0.16% of Morgan Stanley's portfolio in Q1 2026, its #104 holding.
Morgan Stanley first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
Morgan Stanley's Pfizer position peaked at $4.73B in Q4 2023.
2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.